Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Aspirin Bleeding Risks Negated Heart Benefits For Diabetes Patients: Study August 30, 2018 Martha Garcia Add Your Comments Taking a daily aspirin may help prevent heart attacks among individuals with diabetes, but the findings of a new study suggest that it may also significantly increases their risk for serious bleeding problems. In a report published this week in the New England Journal of Medicine, researchers from the U.K. warn that the bleeding risks associated with taking daily aspirin outweigh any potential benefit for those with diabetes. People who have diabetes face a higher risk of heart problems and stroke from blood clots. However, past studies have shown aspirin helps reduce the risk of heart attack in some people. Researchers wanted to see if there was benefit of daily aspirin among patients with diabetes. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Researchers of the ASCEND trial studied nearly 15,500 patients with diabetes over the age of 40 with no prior cardiovascular disease. They were randomly assigned to receive a daily dose of 100 mg of aspirin or a matching daily placebo. Patients with diabetes saw vascular events, such as heart attacks and strokes, reduced by 12%. However, major bleeding increased by nearly 30%. Most of the bleeding involved gastrointestinal bleeding or extra cranial bleeding. “In conclusion, the use of low-dose aspirin led to a lower risk of serious vascular events than placebo among persons with diabetes who did not have evident cardiovascular disease at trial entry,” the researchers determined. “However, the absolute lower rates of serious vascular events were of similar magnitude to the absolute higher rates of major bleeding, even among participants who had a high vascular risk.” Previous studies have linked other painkillers, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), to a similar risk. Another study published in 2017 linked naproxen-based over-the-counter painkillers, such as Aleve and Midol, to increased risk of gastrointestinal bleeding. About one in two American adults take aspirin on a regular basis, many to prevent heart attack or stroke, often on their doctors’ recommendations. Roughly 422 million people around the world have diabetes, according to the World Health Organization. In the United States, about 30 million people, or 9% of the U.S. population, had diabetes in 2015, according to the U.S. Centers for Disease Control and Prevention Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Aspirin, Bleeding, Diabetes, Gastrointestinal Bleeding, Heart Attack, Stroke More Lawsuit Stories Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 January 23, 2026 LINX Reflux Management System Lawsuit Alleges Implant Failed, Requiring Surgical Removal January 23, 2026 Honda Class Action Lawsuit Claims Recall Did Not Fully Address Engine Defect January 23, 2026 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (Posted: today) Lawyers involved in Depo-Provera litigation have agreed to hold the first bellwether trial over brain tumor injuries beginning on December 7, 2026. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (01/14/2026)Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026) Insole Foot Warmer Burns Often Lead to Debridement Surgery and Long-Term Nerve Damage, Lawsuits Allege (Posted: yesterday) Defective heated insoles and electric socks have been linked to severe foot burns that required surgical debridement, with lawsuits now alleging long-term nerve damage and mobility loss. MORE ABOUT: HEATED INSOLE LAWSUITAmazon Heated Insoles Lawsuit Alleges Foot Warmer Burst Into Flames Inside Boot (01/05/2026)Amazon Foot Warmer Lawsuit Alleges Heated Insoles Exploded, Caught Fire (12/10/2025) Ozempic Side Effects Led to Severe Vision Loss, Lawsuit Claims (Posted: 2 days ago) A recent Ozempic NAION lawsuit claims Novo Nordisk knew the drug was linked to vision loss risks for years, but failed to update the label warnings. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (01/13/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)
LINX Reflux Management System Lawsuit Alleges Implant Failed, Requiring Surgical Removal January 23, 2026
Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (Posted: today) Lawyers involved in Depo-Provera litigation have agreed to hold the first bellwether trial over brain tumor injuries beginning on December 7, 2026. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (01/14/2026)Side Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)
Insole Foot Warmer Burns Often Lead to Debridement Surgery and Long-Term Nerve Damage, Lawsuits Allege (Posted: yesterday) Defective heated insoles and electric socks have been linked to severe foot burns that required surgical debridement, with lawsuits now alleging long-term nerve damage and mobility loss. MORE ABOUT: HEATED INSOLE LAWSUITAmazon Heated Insoles Lawsuit Alleges Foot Warmer Burst Into Flames Inside Boot (01/05/2026)Amazon Foot Warmer Lawsuit Alleges Heated Insoles Exploded, Caught Fire (12/10/2025)
Ozempic Side Effects Led to Severe Vision Loss, Lawsuit Claims (Posted: 2 days ago) A recent Ozempic NAION lawsuit claims Novo Nordisk knew the drug was linked to vision loss risks for years, but failed to update the label warnings. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (01/13/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)